The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.…
A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.…
The federal judge overseeing valsartan recall litigation has approved Plaintiff Fact Sheets for both individual and class action claims that the generic hypertension drugs contained cancer-causing impurities.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
Apotex Corp. is the latest drug manufacturer to recall all of its generic Zantac products due to the presence of a chemical impurity which could cause cancer.…
The makers of Zantac face a class action lawsuit from plaintiffs in California, who say they knew or should have known the heartburn drug contained high levels of NDMA; which has been linked to an increased cancer risk.
…
All generic Zantac manufactured and distributed by Sandoz has been recalled due to NDMA contamination.…
Dr. Reddy’s becomes the second drug manufacturer to halt distribution of generic Zantac, which may be contaminated with NDMA, a potentially cancer-causing agent.…
The heartburn drug Zantac is being pulled from the market after a pharmacy found that it contained large amounts of a likely cancer-causing impurity.…
A status conference this week will discuss whether losartan and irbesartan lawsuits should be added to a valsartan recall lawsuit MDL, as all three drugs saw massive recalls over cancer-causing impurities.…
